Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Tuesday's Featured Article 3 Stocks Under $5 With Strong Analyst Upside PotentialAuthor: Chris Markoch. Date Posted: 2/24/2026. 
Summary - Grab Holdings is gaining analyst support as revenue growth and its first full year of profitability highlight long-term opportunity in Southeast Asia’s expanding digital economy.
- Vaxart offers speculative biotech upside with its oral vaccine platform targeting influenza, norovirus, and COVID-19, creating a high-risk, high-reward setup.
- ThredUp is positioned to benefit from the fast-growing resale market, with strong institutional ownership and industry forecasts pointing to sustained secondhand demand.
While many investors are rotating out of speculative penny stocks, others still embrace the risk-reward tradeoff. Stocks that trade for under $5 carry elevated risk: many are unprofitable, and some generate little to no revenue. These are almost always small-cap companies, which have been beaten up in recent years. Even though the Russell 2000 shows some signs of improvement, that momentum hasn't been broad across the small-cap sector. The headlines scream about oil and regime change in the Middle East. But behind the scenes, President Trump is about to unleash something far more shocking in the homeland.
You won't hear about it on Fox Business or CNBC.
But it's about to have a seismic impact on the wealth of every American patriot.
It's the boldest initiative of President Trump's second term by far – and it's not even close. To find out why, and how it could affect your financial future – click here immediately. This could start to change in 2026, particularly if the economic outlook continues to improve and money flows back into speculative names. As with any market segment, however, quality matters. One way to filter for quality is to look for names with positive analyst sentiment. That describes these three stocks. Each lets investors build a meaningful position with a modest outlay while offering the potential for significant upside over the next five years. Profitability Milestone Meets Long-Term Emerging Market Growth Emerging-market stocks are expected to be among the winners in 2026. That hasn't been the case so far for Grab Holdings Inc. (NASDAQ: GRAB), which is down roughly 15% year-to-date. Based in Singapore, Grab operates a super app that combines technology, e-commerce and fintech services. One reason behind the stock's recent pullback is its proposed merger with Indonesian rideshare competitor GoTo. The deal is not finalized and could face legislative changes in Indonesia that might limit the company's earnings potential there. The company also missed revenue expectations slightly in its Q4 2025 earnings report. For context, revenue was up 19% year-over-year (YOY), and this marked the first full year of profit in the company's history. Analysts are forecasting about 120% earnings growth over the next 12 months. That helps explain why sentiment remains generally bullish. GRAB stock has a consensus price target of $6.47, implying roughly 54% upside from its current level. High-Risk Biotech With Platform Potential Penny-stock investors often look to the biotechnology sector, which requires balancing large potential rewards against high risk. One name to watch is Vaxart Inc. (OTCMKTS: VXRT), the only company on this list that meets the classic definition of a penny stock. At the time of writing, it traded just over $0.60 per share. VXRT doesn't have heavy analyst coverage, but the one analyst who issued a rating in the last 12 months rated it a Buy with a $2 price target. It's not unusual for analysts to overlook some biotech firms. Vaxart is a clinical-stage company, meaning all of its candidates remain in clinical trials. The upside, if clinical data proves favorable, is straightforward: the company is developing oral vaccines primarily for influenza, norovirus and COVID-19. Beyond convenience and eliminating needle phobia, Vaxart says its oral platform may elicit a broader immune response that could offer wider protection. VXRT has only about 18% institutional ownership, but in dollar terms inflows have outnumbered outflows by nearly 10-to-1. Resale Tailwinds Could Turn Today's Losses Into Tomorrow's Gains ThredUp Inc. (NASDAQ: TDUP) is down roughly 33% in 2026, but a longer view is instructive: over the last 12 months TDUP is up more than 66%. That frames the recent drop as a typical pullback amid investor caution around unprofitable companies. In ThredUp's case it's worth adding the caveat "yet." The company operates an online consignment and thrift platform that's gaining popularity with Gen Z, reflected in revenue growth. In its most recent quarter, revenue increased 12.5% YOY. ThredUp cites a GlobalData 2025 market survey that forecast the U.S. secondhand market's gross merchandise value would grow at a compound annual growth rate (CAGR) of 9% through 2029. Institutions own an impressive ~89% of TDUP. In dollar terms, buying has outpaced selling roughly two-to-one, and by number of transactions about three-to-one. That said, short interest is around 17%, which can increase near-term volatility. The consensus price target from six analysts is $12.50, implying more than 190% upside from the current price.
| 
